Center for Policy Analysis on Trade and Health - CPATH

CPATH Analysis: TPP IP Text - Tobacco & Health
Home
TPP and Public Health 2016
Public Health on Fast Track: to House W&M 4-22-15
Support Our Work!
PROTECT HEALTH IN TPP
Campaign: Public Health Voice in Trade Policy
Tobacco Control and the TPP
CPATH on Leaked TPP IP Text
Mexico, Chile on TPP-Tobacco
Tobacco & Trade Consortium 2013
2012: Health Advocates Assert Carve-Out; U.S. Weak TPP/Tobacco Proposal
TPP Forums Jan 2012
Trans Pacific Partnership
Tobacco and Trade Publications
Trade Advisory Committees December 2010
Key Trade Agreements - CPATH Analysis and Commentary
Special 301 Hearings: Change Course!
CPATH at APHA 2009 Trade Advisory Committees
CPATH EVENT Aug. 26 2009: CAFTA and Access to Meds
Trade and Health Forum Program APHA Nov. 2009
About CPATH - Overview
CPATH Article: CAFTA Impact on Meds, Prices
Press Release: CPATH on CAFTA in Health Affairs
CAFTA aumenta los precios de medicamentos
Congressional Hearing on Trade Advisory Committees
Towards Change: Korea; Peru; Public Health Objectives
Trade & Health at APHA 2008
Global Trade Events at APHA November 2007
Thailand's Compulsory Licenses for Medicines
Globalization and Health Resource Center - Overview
Key Issues
CPATH Publications
Related Resources
CPATH Presentations
CPATH at US Social Forum 2007
Monterey Forum 2005
FTAA Forum
Public Health Summary Statements on Free Trade Agreements
Resolutions
Sign-On Statements
More About CPATH
Intellectual Property Chapter of Trans-Pacific Partnership Trade Agreement, Tobacco, and Public Health
CPATH Analysis - November 25, 2013 

New analysis of the leaked Intellectual Property Chapter of the Trans-Pacific Partnership Agreement (TPP) finds potential threat to tobacco-control measures, and the sovereign ability of nations to protect public health from tobacco-related disease and death.  (See complete CPATH Analysis.) 

Understandings Regarding Public Health Measures provide significant loopholes for tobacco companies to file trade charges, while offering no clear legal protection of public health. 

Reference to the “TRIPS/health solution” does not apply to tobacco products, or to protection of public health from tobacco-related disease or death.  (Focus on the TRIPS/health solution also limits the right of all TPP countries to provide access of medicines to all, for example, by granting compulsory licenses to produce affordable generic drugs to meet public health needs within their own borders.)

Lack of agreement on language to ensure regulatory coherence between preexisting public health agreements and TPP intellectual property provisions sets the stage for future trade conflicts between the TPP IP Chapter and other agreements which promote public health, such as the Framework Convention on Tobacco Control (FCTC). 

New rights to use trademarks as “geographical indications” could grant new rights to tobacco companies to protect their use of brand-names, such as Marlboro, Winston, and Salem.

Enforcement of IP protections for tobacco companies remain protected under the Investment Chapter.  “Investor-State Dispute Settlement” (ISDS) under the Investment Chapter grants corporations the power to file trade challenges directly against the laws of a nation. The TPP Investment Chapter expands preexisting investment agreements among TPP countries. For example, the TPP Investment chapter could give Philip Morris International, a U.S. investor, standing to challenge the law of a TPP country.

TPP partner countries should advance and reach agreement on proposals that promote public health and stem preventable deaths from diseases related to tobacco, by guaranteeing nations’ sovereign domestic rights and abilities to adopt or maintain measures to reduce tobacco use and to prevent tobacco-related deaths and diseases: 

  1. Exclude tobacco control measures from existing and future trade agreements.
  2. Do not request or agree to lower tariffs on tobacco leaf or products.
  3. Remove investor-state dispute settlement (ISDS) provisions; these grant tobacco corporations rights to contest nations' public health and other policies directly for financial damages through the global trade arena.
  4. Set trade policy through a transparent public process.

Click here for CPATH Analysis

Bringing a Public Health Voice to Global Trade and Sustainable Development
CPATH
Ellen R. Shaffer and Joe Brenner, Co-Directors
P.O. Box 29586, San Francisco, CA 94129
phone 415-922-6204